Harnessing carbon monoxide-releasing platforms for cancer therapy
- 1 October 2020
- journal article
- review article
- Published by Elsevier in Biomaterials
- Vol. 255, 120193
Abstract
No abstract availableKeywords
Funding Information
- Higher Education Discipline Innovation Project
- Science and Technology Department of Sichuan Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
This publication has 141 references indexed in Scilit:
- A peptide-based material for therapeutic carbon monoxide deliverySoft Matter, 2012
- Developing drug molecules for therapy with carbon monoxideChemical Society Reviews, 2012
- Modulation of ion channels and transporters by carbon monoxide: causes for concern?Frontiers in Physiology, 2012
- A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen speciesFree Radical Biology and Medicine, 2011
- Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of CancerMolecules, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Carbon Monoxide Inhibits L-type Ca2+ Channels via Redox Modulation of Key Cysteine Residues by Mitochondrial Reactive Oxygen SpeciesJournal of Biological Chemistry, 2008
- Cancer-related inflammationNature, 2008
- The carbon monoxide‐releasing molecule CORM‐2 inhibits the inflammatory response induced by cytokines in Caco‐2 cellsBritish Journal of Pharmacology, 2007
- CO–metal interaction: vital signaling from a lethal gasTrends in Biochemical Sciences, 2006